 |
PDBsum entry 1jwp
|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
DOI no:
|
J Mol Biol
320:85-95
(2002)
|
|
PubMed id:
|
|
|
|
|
| |
|
Evolution of an antibiotic resistance enzyme constrained by stability and activity trade-offs.
|
|
X.Wang,
G.Minasov,
B.K.Shoichet.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
Pressured by antibiotic use, resistance enzymes have been evolving new
activities. Does such evolution have a cost? To investigate this question at the
molecular level, clinically isolated mutants of the beta-lactamase TEM-1 were
studied. When purified, mutant enzymes had increased activity against
cephalosporin antibiotics but lost both thermodynamic stability and kinetic
activity against their ancestral targets, penicillins. The X-ray
crystallographic structures of three mutant enzymes were determined. These
structures suggest that activity gain and stability loss is related to an
enlarged active site cavity in the mutant enzymes. In several clinically
isolated mutant enzymes, a secondary substitution is observed far from the
active site (Met182-->Thr). This substitution had little effect on enzyme
activity but restored stability lost by substitutions near the active site. This
regained stability conferred an advantage in vivo. This pattern of stability
loss and restoration may be common in the evolution of new enzyme activity.
|
|
|
|
|
| |
Selected figure(s)
|
|
|
| |
 |
 |
|
 |
|
 |
Figure 3.
Figure 3. Comparing the in vivo stabilities of TEM-52
(E104K/M182T/G238S, left) and TEM-15 (E104K/G238S, right) at (a)
42 °C and (b) RT. Plates are representative of five
independent assays for each mutant. The two top disks on each
plate are CAZ and CTX from left to right, and the bottom disk is
AM.
|
 |
Figure 5.
Figure 5. A stereo view of the enlarged active sites of (a)
G238A and (b) TEM-64 (E104K/R164S/M182T). (a) Superposition of
the G238A (carbon atoms colored orange) and WT (magenta, PDB
1XPB[39.]) crystal structures (rms is 0.24 Å for all C^a
atoms). A broken line indicates the putative steric clash
(distance 2.96 Å) between the C^b atom of Ala238 and the
carbonyl oxygen atom of Asn170 that would occur in WT. For
G238A, carbon, nitrogen, and oxygen atoms are colored yellow,
blue, and red, respectively. The catalytic water molecule in WT
(magenta) and G238A (cyan) is shown. (b) Superposition of the
C^a atom of TEM-64 (blue) and penicillin-bound TEM-1 E166N
(orange, PDB 1FQG[33.]) crystal structures (rms is 0.85 Å
for all C^a atoms). The penicillin G acyl-adduct is shown to
identify the active site. The carbon atoms in penicillin G are
colored green, nitrogen atoms blue, oxygen atoms red, and the
sulfur atom yellow.
|
 |
|
|
|
| |
The above figures are
reprinted
by permission from Elsevier:
J Mol Biol
(2002,
320,
85-95)
copyright 2002.
|
|
| |
Figures were
selected
by an automated process.
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
J.L.Myers,
and
S.E.Hensley
(2011).
Oseltamivir-resistant influenza viruses get by with a little help from permissive mutations.
|
| |
Expert Rev Anti Infect Ther,
9,
385-388.
|
 |
|
|
|
|
 |
D.Rodriguez-Larrea,
R.Perez-Jimenez,
I.Sanchez-Romero,
A.Delgado-Delgado,
J.M.Fernandez,
and
J.M.Sanchez-Ruiz
(2010).
Role of conservative mutations in protein multi-property adaptation.
|
| |
Biochem J,
429,
243-249.
|
 |
|
|
|
|
 |
J.D.Bloom,
L.I.Gong,
and
D.Baltimore
(2010).
Permissive secondary mutations enable the evolution of influenza oseltamivir resistance.
|
| |
Science,
328,
1272-1275.
|
 |
|
|
|
|
 |
M.Soskine,
and
D.S.Tawfik
(2010).
Mutational effects and the evolution of new protein functions.
|
| |
Nat Rev Genet,
11,
572-582.
|
 |
|
|
|
|
 |
O.Khersonsky,
and
D.S.Tawfik
(2010).
Enzyme promiscuity: a mechanistic and evolutionary perspective.
|
| |
Annu Rev Biochem,
79,
471-505.
|
 |
|
|
|
|
 |
R.C.MacLean,
A.R.Hall,
G.G.Perron,
and
A.Buckling
(2010).
The population genetics of antibiotic resistance: integrating molecular mechanisms and treatment contexts.
|
| |
Nat Rev Genet,
11,
405-414.
|
 |
|
|
|
|
 |
T.A.Williams,
and
M.A.Fares
(2010).
The effect of chaperonin buffering on protein evolution.
|
| |
Genome Biol Evol,
2,
609-619.
|
 |
|
|
|
|
 |
V.L.Thomas,
A.C.McReynolds,
and
B.K.Shoichet
(2010).
Structural bases for stability-function tradeoffs in antibiotic resistance.
|
| |
J Mol Biol,
396,
47-59.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
C.J.Jackson,
J.L.Foo,
N.Tokuriki,
L.Afriat,
P.D.Carr,
H.K.Kim,
G.Schenk,
D.S.Tawfik,
and
D.L.Ollis
(2009).
Conformational sampling, catalysis, and evolution of the bacterial phosphotriesterase.
|
| |
Proc Natl Acad Sci U S A,
106,
21631-21636.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
C.Montanier,
V.A.Money,
V.M.Pires,
J.E.Flint,
B.A.Pinheiro,
A.Goyal,
J.A.Prates,
A.Izumi,
H.Stålbrand,
C.Morland,
A.Cartmell,
K.Kolenova,
E.Topakas,
E.J.Dodson,
D.N.Bolam,
G.J.Davies,
C.M.Fontes,
and
H.J.Gilbert
(2009).
The active site of a carbohydrate esterase displays divergent catalytic and noncatalytic binding functions.
|
| |
PLoS Biol,
7,
e71.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
E.R.Lozovsky,
T.Chookajorn,
K.M.Brown,
M.Imwong,
P.J.Shaw,
S.Kamchonwongpaisan,
D.E.Neafsey,
D.M.Weinreich,
and
D.L.Hartl
(2009).
Stepwise acquisition of pyrimethamine resistance in the malaria parasite.
|
| |
Proc Natl Acad Sci U S A,
106,
12025-12030.
|
 |
|
|
|
|
 |
J.D.Bloom,
and
F.H.Arnold
(2009).
In the light of directed evolution: pathways of adaptive protein evolution.
|
| |
Proc Natl Acad Sci U S A,
106,
9995.
|
 |
|
|
|
|
 |
J.Paramesvaran,
E.G.Hibbert,
A.J.Russell,
and
P.A.Dalby
(2009).
Distributions of enzyme residues yielding mutants with improved substrate specificities from two different directed evolution strategies.
|
| |
Protein Eng Des Sel,
22,
401-411.
|
 |
|
|
|
|
 |
K.B.Levin,
O.Dym,
S.Albeck,
S.Magdassi,
A.H.Keeble,
C.Kleanthous,
and
D.S.Tawfik
(2009).
Following evolutionary paths to protein-protein interactions with high affinity and selectivity.
|
| |
Nat Struct Mol Biol,
16,
1049-1055.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
K.M.Brown,
M.A.Depristo,
D.M.Weinreich,
and
D.L.Hartl
(2009).
Temporal constraints on the incorporation of regulatory mutants in evolutionary pathways.
|
| |
Mol Biol Evol,
26,
2455-2462.
|
 |
|
|
|
|
 |
N.Tokuriki,
and
D.S.Tawfik
(2009).
Chaperonin overexpression promotes genetic variation and enzyme evolution.
|
| |
Nature,
459,
668-673.
|
 |
|
|
|
|
 |
P.A.Romero,
and
F.H.Arnold
(2009).
Exploring protein fitness landscapes by directed evolution.
|
| |
Nat Rev Mol Cell Biol,
10,
866-876.
|
 |
|
|
|
|
 |
D.C.Marciano,
J.M.Pennington,
X.Wang,
J.Wang,
Y.Chen,
V.L.Thomas,
B.K.Shoichet,
and
T.Palzkill
(2008).
Genetic and structural characterization of an L201P global suppressor substitution in TEM-1 beta-lactamase.
|
| |
J Mol Biol,
384,
151-164.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
F.Bös,
and
J.Pleiss
(2008).
Conserved water molecules stabilize the Omega-loop in class A beta-lactamases.
|
| |
Antimicrob Agents Chemother,
52,
1072-1079.
|
 |
|
|
|
|
 |
M.G.Page
(2008).
Extended-spectrum beta-lactamases: structure and kinetic mechanism.
|
| |
Clin Microbiol Infect,
14,
63-74.
|
 |
|
|
|
|
 |
M.Gniadkowski
(2008).
Evolution of extended-spectrum beta-lactamases by mutation.
|
| |
Clin Microbiol Infect,
14,
11-32.
|
 |
|
|
|
|
 |
M.Perilli,
G.Celenza,
F.De Santis,
C.Pellegrini,
C.Forcella,
G.M.Rossolini,
S.Stefani,
and
G.Amicosante
(2008).
E240V substitution increases catalytic efficiency toward ceftazidime in a new natural TEM-type extended-spectrum beta-lactamase, TEM-149, from Enterobacter aerogenes and Serratia marcescens clinical isolates.
|
| |
Antimicrob Agents Chemother,
52,
915-919.
|
 |
|
|
|
|
 |
N.Tokuriki,
F.Stricher,
L.Serrano,
and
D.S.Tawfik
(2008).
How protein stability and new functions trade off.
|
| |
PLoS Comput Biol,
4,
e1000002.
|
 |
|
|
|
|
 |
R.D.Gupta,
and
D.S.Tawfik
(2008).
Directed enzyme evolution via small and effective neutral drift libraries.
|
| |
Nat Methods,
5,
939-942.
|
 |
|
|
|
|
 |
R.M.Kelly,
H.Leemhuis,
L.Gätjen,
and
L.Dijkhuizen
(2008).
Evolution toward small molecule inhibitor resistance affects native enzyme function and stability, generating acarbose-insensitive cyclodextrin glucanotransferase variants.
|
| |
J Biol Chem,
283,
10727-10734.
|
 |
|
|
|
|
 |
S.Bershtein,
and
D.S.Tawfik
(2008).
Ohno's model revisited: measuring the frequency of potentially adaptive mutations under various mutational drifts.
|
| |
Mol Biol Evol,
25,
2311-2318.
|
 |
|
|
|
|
 |
S.Martí,
J.Andrés,
V.Moliner,
E.Silla,
I.Tuñón,
and
J.Bertrán
(2008).
Computational design of biological catalysts.
|
| |
Chem Soc Rev,
37,
2634-2643.
|
 |
|
|
|
|
 |
H.Takahashi,
M.Arai,
T.Takenawa,
H.Sota,
Q.H.Xie,
and
M.Iwakura
(2007).
Stabilization of hyperactive dihydrofolate reductase by cyanocysteine-mediated backbone cyclization.
|
| |
J Biol Chem,
282,
9420-9429.
|
 |
|
|
|
|
 |
J.D.Bloom,
Z.Lu,
D.Chen,
A.Raval,
O.S.Venturelli,
and
F.H.Arnold
(2007).
Evolution favors protein mutational robustness in sufficiently large populations.
|
| |
BMC Biol,
5,
29.
|
 |
|
|
|
|
 |
N.Doucet,
and
J.N.Pelletier
(2007).
Simulated annealing exploration of an active-site tyrosine in TEM-1 beta-lactamase suggests the existence of alternate conformations.
|
| |
Proteins,
69,
340-348.
|
 |
|
|
|
|
 |
S.G.Peisajovich,
and
D.S.Tawfik
(2007).
Protein engineers turned evolutionists.
|
| |
Nat Methods,
4,
991-994.
|
 |
|
|
|
|
 |
C.R.Bethel,
A.M.Hujer,
K.M.Hujer,
J.M.Thomson,
M.W.Ruszczycky,
V.E.Anderson,
M.Pusztai-Carey,
M.Taracila,
M.S.Helfand,
and
R.A.Bonomo
(2006).
Role of Asp104 in the SHV beta-lactamase.
|
| |
Antimicrob Agents Chemother,
50,
4124-4131.
|
 |
|
|
|
|
 |
D.M.Weinreich,
N.F.Delaney,
M.A.Depristo,
and
D.L.Hartl
(2006).
Darwinian evolution can follow only very few mutational paths to fitter proteins.
|
| |
Science,
312,
111-114.
|
 |
|
|
|
|
 |
G.M.Rossolini,
and
J.D.Docquier
(2006).
New beta-lactamases: a paradigm for the rapid response of bacterial evolution in the clinical setting.
|
| |
Future Microbiol,
1,
295-308.
|
 |
|
|
|
|
 |
J.D.Bloom,
S.T.Labthavikul,
C.R.Otey,
and
F.H.Arnold
(2006).
Protein stability promotes evolvability.
|
| |
Proc Natl Acad Sci U S A,
103,
5869-5874.
|
 |
|
|
|
|
 |
R.Couñago,
S.Chen,
and
Y.Shamoo
(2006).
In vivo molecular evolution reveals biophysical origins of organismal fitness.
|
| |
Mol Cell,
22,
441-449.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
D.D.Jones
(2005).
Triplet nucleotide removal at random positions in a target gene: the tolerance of TEM-1 beta-lactamase to an amino acid deletion.
|
| |
Nucleic Acids Res,
33,
e80.
|
 |
|
|
|
|
 |
F.Robin,
J.Delmas,
C.Chanal,
D.Sirot,
J.Sirot,
and
R.Bonnet
(2005).
TEM-109 (CMT-5), a natural complex mutant of TEM-1 beta-lactamase combining the amino acid substitutions of TEM-6 and TEM-33 (IRT-5).
|
| |
Antimicrob Agents Chemother,
49,
4443-4447.
|
 |
|
|
|
|
 |
J.D.Bloom,
J.J.Silberg,
C.O.Wilke,
D.A.Drummond,
C.Adami,
and
F.H.Arnold
(2005).
Thermodynamic prediction of protein neutrality.
|
| |
Proc Natl Acad Sci U S A,
102,
606-611.
|
 |
|
|
|
|
 |
J.Delmas,
F.Robin,
F.Bittar,
C.Chanal,
and
R.Bonnet
(2005).
Unexpected enzyme TEM-126: role of mutation Asp179Glu.
|
| |
Antimicrob Agents Chemother,
49,
4280-4287.
|
 |
|
|
|
|
 |
M.A.DePristo,
D.M.Weinreich,
and
D.L.Hartl
(2005).
Missense meanderings in sequence space: a biophysical view of protein evolution.
|
| |
Nat Rev Genet,
6,
678-687.
|
 |
|
|
|
|
 |
M.Lunzer,
S.P.Miller,
R.Felsheim,
and
A.M.Dean
(2005).
The biochemical architecture of an ancient adaptive landscape.
|
| |
Science,
310,
499-501.
|
 |
|
|
|
|
 |
P.E.Tomatis,
R.M.Rasia,
L.Segovia,
and
A.J.Vila
(2005).
Mimicking natural evolution in metallo-beta-lactamases through second-shell ligand mutations.
|
| |
Proc Natl Acad Sci U S A,
102,
13761-13766.
|
 |
|
|
|
|
 |
V.K.Dubey,
J.Lee,
and
M.Blaber
(2005).
Redesigning symmetry-related "mini-core" regions of FGF-1 to increase primary structure symmetry: thermodynamic and functional consequences of structural symmetry.
|
| |
Protein Sci,
14,
2315-2323.
|
 |
|
|
|
|
 |
V.L.Thomas,
D.Golemi-Kotra,
C.Kim,
S.B.Vakulenko,
S.Mobashery,
and
B.K.Shoichet
(2005).
Structural consequences of the inhibitor-resistant Ser130Gly substitution in TEM beta-lactamase.
|
| |
Biochemistry,
44,
9330-9338.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
Y.Chen,
B.Shoichet,
and
R.Bonnet
(2005).
Structure, function, and inhibition along the reaction coordinate of CTX-M beta-lactamases.
|
| |
J Am Chem Soc,
127,
5423-5434.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
E.V.Makeyev,
and
D.H.Bamford
(2004).
Evolutionary potential of an RNA virus.
|
| |
J Virol,
78,
2114-2120.
|
 |
|
|
|
|
 |
I.Olesen,
H.Hasman,
and
F.M.Aarestrup
(2004).
Prevalence of beta-lactamases among ampicillin-resistant Escherichia coli and Salmonella isolated from food animals in Denmark.
|
| |
Microb Drug Resist,
10,
334-340.
|
 |
|
|
|
|
 |
J.D.Bloom,
C.O.Wilke,
F.H.Arnold,
and
C.Adami
(2004).
Stability and the evolvability of function in a model protein.
|
| |
Biophys J,
86,
2758-2764.
|
 |
|
|
|
|
 |
T.Shimamura,
A.Ibuka,
S.Fushinobu,
T.Wakagi,
M.Ishiguro,
Y.Ishii,
and
H.Matsuzawa
(2002).
Acyl-intermediate structures of the extended-spectrum class A beta-lactamase, Toho-1, in complex with cefotaxime, cephalothin, and benzylpenicillin.
|
| |
J Biol Chem,
277,
46601-46608.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
X.Wang,
G.Minasov,
and
B.K.Shoichet
(2002).
The structural bases of antibiotic resistance in the clinically derived mutant beta-lactamases TEM-30, TEM-32, and TEM-34.
|
| |
J Biol Chem,
277,
32149-32156.
|
 |
|
PDB codes:
|
 |
|
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
codes are
shown on the right.
|
');
}
}
 |